Annual accounts
Total Exemption Full accounts
31/10/2026Filing deadline
- Next accounts made up to
- 31/01/2026
- Last accounts made up to
- 31/01/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Confirmation statement made on 2026-08-08 with no updates
Director's details changed for Dr Anthony Kent Hall on 2025-12-03
Director's details changed for Mr Andrew Milligan on 2025-12-03
Director's details changed for Mrs Sophie Costello on 2025-12-03
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/10/2026Filing deadline
Confirms the registry record is up to date
22/08/2027Filing deadline
The latest figures BEACON: FOR RARE DISEASES LTD filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £147.01K
Total Assets
2023: £151.45K
Cash in Bank
2023: £146.87K
Total Liabilities
2023: £4.44K
Employees
2023: 8
Of the 4 measures with an earlier filing to compare against, 4 rose. Cash in bank moved furthest, up 30.67% on 2023. See the full financial analysis for BEACON: FOR RARE DISEASES LTD.
The full financial record
Four ways through BEACON: FOR RARE DISEASES LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 10 | +2 |
| 2023 | 8 | +2 |
| 2022 | 6 | +1 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 10 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 10/08/2012–07/11/2025 | 9 | |
| Director | 03/12/2025–Present | 0 | |
| Director | 11/10/2019–Present | 6 | |
| Director | 10/08/2012–25/11/2024 | 12 | |
| Director | 10/08/2012–Present | 6 | |
| Director | 11/10/2019–Present | 7 | |
| Director | 10/08/2012–Present | 0 | |
| Director | 03/12/2025–Present | 3 | |
| Director | 03/12/2025–Present | 0 | |
| Director | 03/12/2025–14/07/2026 | 0 | |
| Director | 03/12/2025–Present | 1 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 10/08/2016–Present | 0 |
Every document on the Companies House record, newest first.
Confirmation statement made on 2026-08-08 with no updates
Director's details changed for Dr Anthony Kent Hall on 2025-12-03
Director's details changed for Mr Andrew Milligan on 2025-12-03
Director's details changed for Mrs Sophie Costello on 2025-12-03
Appointment of Ms Shannon Marie Gunn as a director on 2025-12-03
Appointment of Mr Michael Paul Wilbur as a director on 2025-12-03
Appointment of Dr Kamlesh Kanaiyalal Sheth as a director on 2025-12-03
Appointment of Mr Scott Robin Hutchings as a director on 2025-12-03
Appointment of Dr Rebecca Alice Godfrey as a director on 2025-12-03
Termination of appointment of Edna Kissmann as a director on 2025-11-07
Total exemption full accounts made up to 2025-01-31
Confirmation statement made on 2025-08-08 with no updates
Showing 12 of 47 filings
See when the next accounts and confirmation statement are due
3 UK companies are similar to BEACON: FOR RARE DISEASES LTD, sharing the same company status (Active), the same industry sector and activity group (Other human health activities) and a comparable number of employees. The 3 closest matches are shown below to help you compare competitors and industry peers.
17 Esplanade, Whitley Bay, Tyne And Wear NE26 2AH
13 The Crescent, Marchwood, Southampton SO40 4WS
128 City Road, London EC1V 2NX
A short description of the company, written from its Companies House record.
BEACON: FOR RARE DISEASES LTD is a private limited by guarantee without share capital registered in the United Kingdom, based in 66 Devonshire Road, Cambridge CB1 2BL. Companies House classifies its business as Other human health activities. It has been on the register for 14 years 1 month.
The register currently records it as active. Its 2024 accounts report net assets of £191.48K and 10 employees.
Answered from this company's own registry record and filed figures.
Companies House records BEACON: FOR RARE DISEASES LTD under one registered business activity: Other human health activities (86.90 - SIC 2007).
BEACON: FOR RARE DISEASES LTD is recorded as active on the Companies House register, and has been on it since 10/08/2012.
The most recent accounts Okredo holds cover 2024 and report net assets of £191.48K, total assets of £196.28K, cash in bank of £191.91K and total liabilities of £4.80K.
The most recent document on the record is dated 21/08/2026: Confirmation statement made on 2026-08-08 with no updates, 1 month ago.
On the current registry record, accounts are due by 31/10/2026 and the next confirmation statement is due by 22/08/2027.
Companies House lists 11 officers (8 currently in post) and 1 person with significant control.